Please login to the form below

Not currently logged in
Email:
Password:

OctreoPharm

This page shows the latest OctreoPharm news and features for those working in and with pharma, biotech and healthcare.

Ipsen searches for new CEO after splitting top roles

Ipsen searches for new CEO after splitting top roles

The company has also been building up its neuroendocrine tumours (NET) franchise, recently launching Somatuline (lanreotide) in the US and Europe and acquiring OctreoPharm Sciences, which has a NET therapy in

Latest news

  • Ipsen acquires OctreoPharm to boost its oncology presence Ipsen acquires OctreoPharm to boost its oncology presence

    OctreoPharm focuses on the development of innovative radioactive labelled compounds for molecular imaging and diagnostics and therapeutic applications. . ... OctreoPharm has a unique expertise in antagonist peptides for the diagnosis and treatment of

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics